Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.
Saved in:
| Title: | Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results. |
|---|---|
| Authors: | Labadzhyan A; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Artak.Labadzhyan@cshs.org., Nachtigall LB; MGH Neuroendocrine and Pituitary Center, Chestnut Hill, MA, USA., Fleseriu M; Pituitary Center, Oregon Health & Sciences University, Portland, OR, USA., Gordon MB; Allegheny Neuroendocrinology Center, Allegheny General Hospital, Pittsburgh, PA, USA., Molitch M; Northwestern University, Chicago, IL, USA., Kennedy L; Cleveland Clinic Foundation, Cleveland, OH, USA., Samson SL; Mayo Clinic, Jacksonville, FL, USA., Greenman Y; Sourasky Medical Center and Tel Aviv University, Tel Aviv, Israel., Biermasz N; Leiden University Medical Center, Leiden, The Netherlands., Bolanowski M; Wroclaw Medical University, Wroclaw, Poland., Haviv A; Chiasma, Inc., Needham, MA, USA., Ludlam W; Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Patou G; Chiasma, Inc., Needham, MA, USA., Strasburger CJ; Charite Universitatsmedizin, Berlin, Germany. |
| Source: | Pituitary [Pituitary] 2021 Dec; Vol. 24 (6), pp. 943-953. Date of Electronic Publication: 2021 Jun 25. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7403 (Electronic) Linking ISSN: 1386341X NLM ISO Abbreviation: Pituitary Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
